CompletedPhase 1

Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans

Lead sponsor

University Hospital, Basel, Switzerland

Asset

Avexitide

Listed sites

Recruiting sites

Actual enrollment

Study population

Eligibility highlights

•BMI 19-25•Male•Healthy volunteers

Primary endpoint

Registered trial locations

Locations reported to ClinicalTrials.gov for this trial snapshot. Site count is not enrollment count; per-site enrollment is not available from source.

Identifiers

Registered as

NCT IDNCT01900340

Org study IDEKBB 25/11

Timeline

Milestones

Study first posted2013-07-16estimated

Last update posted2013-07-16estimated

Study start2011-11 (month precision)

Primary completion2012-12actual (month precision)

Study completion2012-12actual (month precision)

Assets

Investigational agents

Avexitide

Who can enroll

Minimum age18 Years

Maximum age45 Years

SexMale

Healthy volunteersAccepted

Inclusion criteria

1. Healthy male subject with a BMI of 19-25 m2/kg

2. Stable body weight for at least three months

3. Normal eating habits

4. Age between 18 and 45 years

5. Sufficient understanding of the German language

6. Subjects understand the procedures and the risks associated with the study

7. Participants must be willing to adhere to the protocol and sign the consent form

Exclusion criteria

1. Participation in another clinical trial (currently or within the last 30 days)

2. Smoking

3. Substance abuse

4. Regular intake of medications (except for oral contraceptives)

5. Chronic or acute medical condition including clinically relevant abnormality in physical exam or laboratory values

6. History of gastrointestinal disorders

7. Food allergies

Endpoints (0)

What's being measured

Protocol endpoints and posted registry outcome measures, grouped into outcome categories. Composite endpoints show their component event types. Standard codes (LOINC, SNOMED CT) are shown where available.

No endpoints recorded for this trial.

Provenance

Sources

Trial identity, design, statusClinicalTrials.gov API v2

Snapshot dateJuly 6, 2026

Endpoint classificationDelfa endpoint taxonomy v2 (May 13, 2026)

Results tableno registry results posted yet

Trial facts come from public ClinicalTrials.gov records. Endpoint categories are Delfa's classification of those records, not a ClinicalTrials.gov field. All figures reflect the July 6, 2026 snapshot.